Royal Philips Electronics and RXi Pharmaceuticals Corporation, a US-based biopharmaceutical company, announced that they have entered into a joint research agreement to explore the benefits of combining proprietary technologies from both companies for the targeted delivery of experimental therapeutics based on RNA interference (RNAi).
Federal health regulators said that Pfizer has agreed to pull the leukemia drug Mylotarg off the market after a follow-up study showed it failed to slow the disease.
A year after a new law put tobacco regulation in the hands of the FDA, one thing is clear: It will likely be years before any of the most aggressive steps to reduce deaths from smoking might happen.
Wolfe Laboratories is a biopharmaceutical development services company that offers customized translational research services and comprehensive IND-enabling programs for biologics and small molecules.
Taconic, a leading provider of life science solutions to researchers worldwide, offers innovative animal models and scientific services for in vivo biomedical studies.
Ricerca Biosciences provides a comprehensive suite of services to support drug candidates. Chemistry capabilities include discovery, medicinal and API process, cGMP manufacturing and scale-up.
Thermo Fisher Scientific Inc. announced additional new phases to its flagship range of Thermo Scientific Hypersil GOLD high performance liquid chromatography (HPLC) columns.
Bio-Rad Laboratories introduces SsoFast probes supermix, a reagent which enables researchers using fluorogenic probes to enhance the speed, reliability, and sensitivity of their qPCR experiments.
Esperion Therapeutics announced that TransGenRx will produce protein-based therapeutics to be used in the company’s research efforts targeting HDL therapies for the treatment of cardio-metabolic disease.
Quotient Bioresearch, a provider of early stage and specialist drug development services to pharmaceutical and biotechnology clients worldwide, announced that its new, state-of-the-art radiochemistry facility in Cardiff, UK is fully operational.
Obese people without metabolic risk factors for diabetes and heart disease, such as high blood pressure and cholesterol, do not have the elevated cardiovascular risk typical of obesity, but they represent only a small percentage of the obese population, according to a long-term study.
Scientists at Dana-Farber Cancer Institute have found a way to disable a common protein that often thwarts chemotherapy treatment of several major forms of cancer.
The Supreme Court is allowing a new trial in the case of a woman who got breast cancer after taking hormone replacement therapy and is seeking punitive damages against Wyeth Pharmaceuticals.
Radius Health announced positive results from a Phase 2a clinical trial of the Company’s RAD1901 selective estrogen receptor modulator (SERM) in relieving menopausal hot flashes.
Kowa Pharmaceuticals America, Inc., and Eli Lilly and Company announced that LIVALO (pitavastatin) tablets is now available in retail pharmacies throughout the United States.